SPY423.44-0.87 -0.21%
DIA343.75-1.37 -0.40%
IXIC14,076.26+6.84 0.05%

Dr. Reddy's Laboratories Launches Generic Invanz in US

05/11/2021 23:39

03:39 AM EDT, 05/12/2021 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) said Wednesday it has launched in the US the generic version of Invanz, or ertapenem for injection, in 1 g/vial variation for the treatment of various bacterial infections.

In the most recent 12 months ending March, the Invanz brand and generic market had US sales of about $205 million, the company said, citing data from IQVIA Health.

Price: 71.77, Change: -0.43, Percent Change: -0.60